Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension.
Justin K LuiRuchika A SanganiKari R GillmeyerJasmine VakhshoorzadehMarcin A TrojanowskiAndreea M BujorDeepa M GopalRenda Soylemez WienerMichael P LaValleyElizabeth S KlingsPublished in: Cardiovascular drugs and therapy (2023)
In patients with precapillary SSc-PH, PAWP was associated with time to hemodynamic response, suggesting the importance of subclinical cardiac disease in determining hemodynamic response to oral vasodilator therapy.